Rob Koremans - Articles and news items

TEVA LOGO

Teva announces full FDA approval of SYNRIBO® (Omacetaxine Mepesuccinate) for injection

Industry news / 13 February 2014 / Teva

24-month FDA post marketing commitment completed…

TEVA LOGO

Teva receives European Marketing Authorization for Lonquex® (XM22 lipegfilgrastim)

Industry news, News / 8 August 2013 / Teva Pharmaceutical Industries Ltd

TEVA announced that the European Commission has granted marketing authorization for Lonquex® (lipegfilgrastim)…

TEVA LOGO

Teva’s Lonquex® (XM22 lipegfilgrastim) recommended for approval in the EU

Industry news, News / 3 June 2013 / Teva Pharmaceutical Industries Ltd

Teva’s Lonquex® (XM22 lipegfilgrastim) recommended for approval in the EU for the reduction of CIN…

 

The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...
+